Materias dentro de su búsqueda.
Mostrando 1,381 - 1,400 Resultados de 15,611 Para Buscar '"pancreatic cancer"', tiempo de consulta: 1.69s Limitar resultados
  1. 1381
    por Salom, Federico, Prat, Frédéric
    Publicado 2022
    “…Interventional EUS has modified the therapeutic approach, primarily for advanced pancreatic cancer. EUS-guided fiducial placement for local targeted radiotherapy treatment or EUS-guided radiofrequency ablation has been developed for local treatment, especially for patients with pancreatic cancer not suitable for surgical resection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Current role of endoscopic ultrasound in the diagnosis and management of pancreatic cancer
  2. 1382
    por Wirth, Matthias
    Publicado 2022
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Targeting the translational machinery to overcome apoptosis resistance in pancreatic cancer
  3. 1383
    “…BACKGROUND: Sodium glucose transporters (SGLTs) play vital roles in glucose uptake in many solid cancers, including pancreatic cancer (PC). However, their expression profile in pancreatic cancer and correlation with prognosis are not clear. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The expression and survival significance of sodium glucose transporters in pancreatic cancer
  4. 1384
    “…BACKGROUND: Pancreatic cancer is a highly aggressive cancer featured by early metastasis and multiple chemoresistance. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy
  5. 1385
    “…Pancreatic exocrine insufficiency (PEI) is a common condition in patients with pancreatic cancer (PC). PEI can be due to the tumor, which, if located in the head, causes obstruction of the pancreatic duct with subsequent atrophy of the pancreatic parenchyma, or it can be the consequence of pancreatic surgical resection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer
  6. 1386
    “…The purpose of this study was to perform qualitative and quantitative characterization of small-molecule profiles of EVs derived from various pancreatic cancer (PC) and normal pancreas cell lines, to provide proof-of-concept for evaluating the efficacy of leveraging EVs as potential biomarkers of PDAC. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    4287 Extracellular vesicles as biomarkers for early detection of pancreatic cancer
  7. 1387
    “…Pancreatic ductal adenocarcinoma (PDAC) is the most frequent pancreatic cancer type, characterized by a dismal prognosis due to late diagnosis, frequent metastases, and limited therapeutic response to standard chemotherapy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells
  8. 1388
    “…Here we evaluate the potency and efficacy of 2,025 clinically relevant two-drug combinations, generating a dataset encompassing 125 molecularly characterized breast, colorectal and pancreatic cancer cell lines. We show that synergy between drugs is rare and highly context-dependent, and that combinations of targeted agents are most likely to be synergistic. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effective drug combinations in breast, colon and pancreatic cancer cells
  9. 1389
    “…This review aims to summarize the current pre-clinical and clinical evidence regarding the effects of exosomal applications in the timely diagnosis, prognosis, and therapeutic management of pancreatic cancer.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?
  10. 1390
    “…Research from epidemiologic studies and experimental animal models provide insights into the role of pancreatic steatosis in the development of pancreatic cancer. Epidemiologic data demonstrate that pancreatic steatosis is widely prevalent and significantly associated with both development and progression of pancreatic cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Uniting Epidemiology and Experimental Models: Pancreatic Steatosis and Pancreatic Cancer
  11. 1391
    “…SIMPLE SUMMARY: Pancreatic cancer is one of the most heterogeneous and aggressive tumours that exist. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer
  12. 1392
    “…Pancreatic cancer is a highly fatal malignant tumor of the digestive system. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Solasonine Inhibits Pancreatic Cancer Progression With Involvement of Ferroptosis Induction
  13. 1393
    “…BACKGROUND: We assessed radiation treatment (RT) use and complications for unresectable pancreatic cancer in the US, comparing conventionally fractionated (CFRT) and stereotactic body radiation treatment (SBRT) to inform real-world expected outcomes and practice. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer
  14. 1394
    por Gu, Xiaojing, Zhou, Wei, Han, Juan
    Publicado 2022
    “…OBJECTIVE: Pancreatic cancer is one of the deadliest solid malignancies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Factors Affecting the Readmission of Patients with Pancreatic Cancer after Surgery
  15. 1395
    “…BACKGROUND: Pancreatic cancer patients often present with complications, which can impact treatment tolerance. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Improving Palliative Care and Quality of Life in Pancreatic Cancer Patients
  16. 1396
    por Porta, Miquel, Gasull, Magda, Pumarega, José, Kiviranta, Hannu, Rantakokko, Panu, Raaschou-Nielsen, Ole, Bergdahl, Ingvar A, Sandanger, Torkjel Manning, Agudo, Antoni, Rylander, Charlotta, Nøst, Therese Haugdahl, Donat-Vargas, Carolina, Aune, Dagfinn, Heath, Alicia K, Cirera, Lluís, Goñi-Irigoyen, Fernando, Alguacil, Juan, Giménez-Robert, Àlex, Tjønneland, Anne, Sund, Malin, Overvad, Kim, Mancini, Francesca Romana, Rebours, Vinciane, Boutron-Ruault, Marie-Christine, Kaaks, Rudolf, Schulze, Matthias B, Trichopoulou, Antonia, Palli, Domenico, Grioni, Sara, Tumino, Rosario, Naccarati, Alessio, Panico, Salvatore, Vermeulen, Roel, Quirós, J Ramón, Rodríguez-Barranco, Miguel, Colorado-Yohar, Sandra M, Chirlaque, María-Dolores, Ardanaz, Eva, Wareham, Nick, Key, Tim, Johansson, Mattias, Murphy, Neil, Ferrari, Pietro, Huybrechts, Inge, Chajes, Veronique, Gonzalez, Carlos Alberto, Bueno-de-Mesquita, Bas, Gunter, Marc, Weiderpass, Elisabete, Riboli, Elio, Duell, Eric J, Katzke, Verena, Vineis, Paolo
    Publicado 2021
    “…BACKGROUND: Findings and limitations of previous studies on persistent organic pollutants (POPs) and pancreatic cancer risk support conducting further research in prospective cohorts. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Plasma concentrations of persistent organic pollutants and pancreatic cancer risk
  17. 1397
    “…The mainstay treatment for patients with immediate resectable pancreatic cancer remains upfront surgery, which represents the only potentially curative strategy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
  18. 1398
    “…Pancreatic cancer (PC) is one of the most lethal cancers with an almost 10% 5-year survival rate. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pancreatic Cancer: Nucleic Acid Drug Discovery and Targeted Therapy
  19. 1399
    “…Sadly, the use of immunotherapy has yet to bring significant clinical breakthrough among pancreatic cancer patients, suggesting that pancreatic cancer has successfully evaded immunomodulation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Targeting pancreatic cancer immune evasion by inhibiting histone deacetylases
  20. 1400
    “…Herein, we present a drug delivery strategy for photosensitizers based on a new liquid metal nanoplatform that leverages the tumor microenvironment to achieve photodynamic therapeutic effects in pancreatic cancer. Eutectic gallium indium (EGaIn) nanoparticles were successfully conjugated with a water-soluble cancer targeting ligand, hyaluronic acid, and a photosensitizer, benzoporphyrin derivative, creating EGaIn nanoparticles (EGaPs) via a simple green sonication method. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Eutectic Gallium–Indium Nanoparticles for Photodynamic Therapy of Pancreatic Cancer
Herramientas de búsqueda: RSS